Journal
SCIENCE TRANSLATIONAL MEDICINE
Volume 3, Issue 107, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.3002878
Keywords
-
Categories
Funding
- Vaccine Research Center
- NIAID
- National Cancer Institute at NIH
Ask authors/readers for more resources
Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
